首页 › 基金 › Artia Global Partners LP › ORKA
Artia Global Partners LP 对 ORKA 的持仓历史
ORUKA THERAPEUTICS INC · 医疗保健
Artia Global Partners LP 在 Q3 2026 的 13F 申报中披露持有 ORKA(ORUKA THERAPEUTICS INC)33,400 股,市值约 US$2.8M,约占其申报组合的 0.56%,在其申报持仓中市值排名第 37 位。 Artia Global Partners LP 最近 7 个申报季度中有 3 个季度披露了 ORKA 持仓,最早可追溯至 Q1 2025。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Artia Global Partners LP 对 ORKA 的持仓演变
Artia Global Partners LP 于 Q1 2025 首次披露 ORKA 持仓:7,380 股(约 US$76K)。 该持仓在 Q2 2026 达到峰值 33,400 股,市值约 US$3.2M。 在 3 次申报中,Artia Global Partners LP 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 33,400 股、市值约 US$2.8M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2025 | 7.38K | $75.72K | 新进 |
| Q2 2026 | 33.40K | $3.18M | 新进 |
| Q3 2026 | 33.40K | $2.78M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ORKA 与 13F 数据
ORKA(ORUKA THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 77 只申报持有 ORKA,申报仓位最大的包括:Venrock Adviser, LLC (US$394.8M), Fairmount Funds Management LLC (US$352.6M), RTW INVESTMENTS, LP (US$261.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ORKA 的基金
- Venrock Adviser, LLC 4.15M 股 · $394.81M · Q2 2026
- Fairmount Funds Management LLC 3.71M 股 · $352.63M · Q2 2026
- RTW INVESTMENTS, LP 3.14M 股 · $261.45M · Q3 2026
- Paradigm Biocapital Advisors LP 2.49M 股 · $207.68M · Q3 2026
- Bellevue Group AG 1.66M 股 · $157.71M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 1.55M 股 · $147.95M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.35M 股 · $128.01M · Q2 2026
- Deep Track Capital, LP 1.07M 股 · $89.10M · Q3 2026
- Remedium Capital Partners, LLC 954.15K 股 · $79.47M · Q3 2026
- Avidity Partners Management LP 760.42K 股 · $72.37M · Q2 2026
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 723.92K 股 · $60.30M · Q3 2026
- Cormorant Asset Management, LP 533.34K 股 · $50.76M · Q2 2026
更多关于 Artia Global Partners LP
常见问题
How long has Artia Global Partners LP held ORKA?
Artia Global Partners LP has disclosed ORKA holdings in 3 of the last 7 reported quarters, going back to Q1 2025.
What is Artia Global Partners LP's current position in ORKA?
As of Q3 2026, Artia Global Partners LP holds 33.40K shares of ORKA (ORUKA THERAPEUTICS INC), valued at $2.78M, representing 0.56% of its reported portfolio and ranking #37.
Has Artia Global Partners LP been buying or selling ORKA?
In the latest 13F filing (Q3 2026), Artia Global Partners LP held unchanged its position in ORKA. The position peaked in Q2 2026 at 33.40K shares.
Which other funds hold ORKA?
Other major institutional holders of ORKA include Venrock Adviser, LLC, Fairmount Funds Management LLC, RTW INVESTMENTS, LP, among 77 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.